Buy Unicycive Ahead of NDA Resubmission - High-Conviction Swing Trade on Regulatory Reassessment
Unicycive (UNCY) is a speculative buy ahead of an expected NDA resubmission and renewed FDA inspection focus. The company trades at a sub-$200M market cap with clear binary catalysts, a compact share float, and signs of improving technical momentum. This trade plan targets a mid-term recovery while acknowledging elevated regulatory and legal risk.